BioSpace News Archive

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of guidelines by the American College of Obstetricians and Gynecologists (ACOG) that support the use of transcervical radiofrequency ablation as a minimally invasive, uterine preserving option for women suffering from symptomatic uterine fibroids.

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced that management will participate in two investor conference events during the month of June 2021.

Tauriga Sciences, Inc., a New York based diversified Life Sciences Company, introduced the Company’s Super Deluxe Rainbow Pack, which is comprised of 1 Blister Pack.

The Ohio State University Wexner Medical Center, one of the nation’s top-ranked academic health centers, and DispatchHealth, a leading provider of in-home medical care, have partnered to offer patients an expanded opportunity to receive convenient and safe medical care in the comfort of their own homes.

nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has successfully achieved the primary endpoint for the nanoMesh™ Pathogen Inhibiting Protein (PIP) uptake studies

Shareholders are invited to the following scheduled Zoom meeting, per the information circular mailed to all shareholders of record.

Ipsen, a global specialty biopharmaceutical group, announces the launch of an Employee Shareholding plan.

According to The Insight Partners market research study titled “3D Printed Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Dosage Forms and Technology,” the global 3D printed drugs market is expected to reach US$ 57.03 Mn in 2027 from US$ 28.52 Mn in 2019.

Arthrosi Therapeutics, Inc. announced results from its Phase 2a study investigating the efficacy and safety of its potent urate lowering agent AR882

However, security and privacy issues, and unaddressed regulatory concerns restrain the market growth.